SG11201504392XA - Anti-mif antibody cell migration assay - Google Patents
Anti-mif antibody cell migration assayInfo
- Publication number
- SG11201504392XA SG11201504392XA SG11201504392XA SG11201504392XA SG11201504392XA SG 11201504392X A SG11201504392X A SG 11201504392XA SG 11201504392X A SG11201504392X A SG 11201504392XA SG 11201504392X A SG11201504392X A SG 11201504392XA SG 11201504392X A SG11201504392X A SG 11201504392XA
- Authority
- SG
- Singapore
- Prior art keywords
- cell migration
- migration assay
- mif antibody
- antibody cell
- mif
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
- G01N2333/4704—Inhibitors; Supressors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/99—Isomerases (5.)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261734845P | 2012-12-07 | 2012-12-07 | |
| US201361778141P | 2013-03-12 | 2013-03-12 | |
| PCT/EP2013/075643 WO2014086916A1 (en) | 2012-12-07 | 2013-12-05 | Anti-mif antibody cell migration assay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201504392XA true SG11201504392XA (en) | 2015-07-30 |
Family
ID=49709694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504392XA SG11201504392XA (en) | 2012-12-07 | 2013-12-05 | Anti-mif antibody cell migration assay |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150309012A1 (en) |
| EP (1) | EP2929348B1 (en) |
| JP (1) | JP2016502669A (en) |
| KR (1) | KR20150091504A (en) |
| CN (1) | CN104884955B (en) |
| AU (1) | AU2013354035A1 (en) |
| CA (1) | CA2893249A1 (en) |
| HK (1) | HK1216265A1 (en) |
| NZ (1) | NZ628794A (en) |
| SG (1) | SG11201504392XA (en) |
| WO (1) | WO2014086916A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016156489A1 (en) | 2015-03-31 | 2016-10-06 | Baxalta GmbH | Dosage regimen for anti-mif antibodies |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6645493B1 (en) | 1993-05-17 | 2003-11-11 | The Picower Institute For Medical Research | Composition containing anti-MIF antibody |
| US20030235584A1 (en) | 2000-02-28 | 2003-12-25 | Kloetzer William S. | Method for preparing anti-MIF antibodies |
| JP2004516038A (en) * | 2000-12-22 | 2004-06-03 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | Methods for identifying substances that positively affect the inflammatory condition of chronic inflammatory airway disease |
| US20030186300A1 (en) * | 2002-03-20 | 2003-10-02 | Ali Akoum | Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment of related conditions |
| WO2004080273A2 (en) * | 2003-03-12 | 2004-09-23 | Rappaport Family Institute For Research In The Medical Sciences | Compositions and methods for diagnosing and treating prostate cancer |
| US20050202010A1 (en) * | 2003-08-29 | 2005-09-15 | Giroir Brett P. | Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor |
| DK2101805T3 (en) * | 2007-01-18 | 2013-01-21 | Merck Patent Gmbh | INTEGRIC LANDS FOR USE IN CANCER TREATMENT |
| AU2008346517B2 (en) * | 2008-01-04 | 2013-12-05 | Baxalta GmbH | Anti MIF antibodies |
| CN101709088A (en) * | 2009-12-04 | 2010-05-19 | 上海市免疫学研究所 | Monoclonal antibody for resisting Cyr61 protein and application thereof |
| WO2012031099A2 (en) * | 2010-09-02 | 2012-03-08 | Vaccinex, Inc. | Anti-cxcl13 antibodies and methods of using the same |
-
2013
- 2013-12-05 JP JP2015546008A patent/JP2016502669A/en not_active Withdrawn
- 2013-12-05 EP EP13799325.9A patent/EP2929348B1/en active Active
- 2013-12-05 WO PCT/EP2013/075643 patent/WO2014086916A1/en active Application Filing
- 2013-12-05 US US14/649,509 patent/US20150309012A1/en not_active Abandoned
- 2013-12-05 CA CA2893249A patent/CA2893249A1/en not_active Abandoned
- 2013-12-05 NZ NZ628794A patent/NZ628794A/en unknown
- 2013-12-05 CN CN201380064094.2A patent/CN104884955B/en active Active
- 2013-12-05 KR KR1020157017747A patent/KR20150091504A/en not_active Application Discontinuation
- 2013-12-05 SG SG11201504392XA patent/SG11201504392XA/en unknown
- 2013-12-05 AU AU2013354035A patent/AU2013354035A1/en not_active Abandoned
-
2016
- 2016-04-14 HK HK16104254.5A patent/HK1216265A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2929348B1 (en) | 2017-05-10 |
| KR20150091504A (en) | 2015-08-11 |
| CN104884955B (en) | 2017-06-27 |
| AU2013354035A1 (en) | 2015-06-11 |
| US20150309012A1 (en) | 2015-10-29 |
| EP2929348A1 (en) | 2015-10-14 |
| JP2016502669A (en) | 2016-01-28 |
| CN104884955A (en) | 2015-09-02 |
| NZ628794A (en) | 2016-03-31 |
| HK1216265A1 (en) | 2016-10-28 |
| WO2014086916A1 (en) | 2014-06-12 |
| CA2893249A1 (en) | 2014-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1251033A1 (en) | Whole cell assays and methods | |
| HK1216907A1 (en) | Single cell bar-coding for antibody discovery | |
| DK2934584T3 (en) | ANTI-GDF15 ANTIBODIES | |
| HK1215970A1 (en) | Quantitative lateral flow assay | |
| DK2850101T3 (en) | Anti-FcRn antibodies | |
| HK1204571A1 (en) | Protease-regulated antibodies | |
| DK3467500T3 (en) | Cobinder-supported assay methods | |
| HK1210192A1 (en) | Anti-siglec-15 antibodies siglec-15 | |
| IL235059A0 (en) | Anti-il-23p19 antibodies | |
| DK3517956T3 (en) | MODIFICATION DEPENDENT ACTIVITY ASSAYS | |
| EP2930240A4 (en) | Anti-folr1 antibody | |
| DE112013002360T8 (en) | The reagent | |
| ZA201407316B (en) | Anti-fgfr2 antibody | |
| EP2826790A4 (en) | Gremlin-1 antibody | |
| ZA201407079B (en) | Cdr-modified anti-siglec-15 antibody | |
| DK2828292T3 (en) | JCV-NEUTRALIZING ANTIBODIES | |
| HK1210186A1 (en) | Anti-h7cr antibodies h7cr | |
| DK3521315T3 (en) | Anti-transglutaminase-2 antibodies | |
| GB201220662D0 (en) | Assays | |
| GB201118293D0 (en) | Electrochemical assay | |
| DK2935330T3 (en) | ANTI-NOTCH3 ANTIBODIES | |
| EP2904394A4 (en) | Multi-analyte assay | |
| GB201220242D0 (en) | Antibody | |
| GB201212550D0 (en) | B cell assay | |
| HK1216265A1 (en) | Anti-mif antibody cell migration assay -mif |